Intravitreal Dexamethason treatment of bacterial endophthalmitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28649

Enrollment

150

Registered

2005-08-23

Start date

2003-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endophthalmitis

Interventions

Intravitreal injection of 400 ìg examethason or placebo.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Post-cataract bacterial endophthalmitis; 2. Strong, and increasing, irritation of anterior chamber and/or vitreous during postoperative 8 weeks interval.

Exclusion criteria

Exclusion criteria: Antibiotics treatment.

Design outcomes

Primary

Measure	Time frame
Vision (ETDRS) after 3, 6 and 12 months, panbacterial PCR.	—

Contacts

Public ContactJ.C. Meurs, van

Oogziekenhuis Rotterdam, Schiedamsevest 180

vanMeurs@oogziekenhuis.nl+31 (0)10 4017777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)